Fady Ibraham Malik - 09 Dec 2021 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP Research & Development
Signature
By: Robert Wong For: Fady Malik
Issuer symbol
CYTK
Transactions as of
09 Dec 2021
Net transactions value
-$880,542
Form type
4
Filing time
09 Dec 2021, 18:02:49 UTC
Previous filing
12 Nov 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $40,490 +6,427 +4.3% $6.30* 155,741 09 Dec 2021 Direct F1, F2
transaction CYTK Common Stock Sale $234,526 -6,427 -4.1% $36.49 149,314 09 Dec 2021 Direct F1, F2
transaction CYTK Common Stock Options Exercise $143,256 +22,739 +15% $6.30* 172,053 09 Dec 2021 Direct F1, F2
transaction CYTK Common Stock Sale $829,762 -22,739 -13% $36.49 149,314 09 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Incentive Stock Option (right to buy) Options Exercise $0 -22,739 -100% $0.000000* 0 09 Dec 2021 Common Stock 22,739 $6.30 Direct F1
transaction CYTK Non-Qualified Stock Option (right to buy) Options Exercise $0 -6,427 -100% $0.000000* 0 09 Dec 2021 Common Stock 6,427 $6.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020.
F2 Includes 2,436 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).